Authors:
Bing, C
Taylor, S
Tisdale, MJ
Williams, G
Citation: C. Bing et al., Cachexia in MAC16 adenocarcinoma: Suppression of hunger despite normal regulation of leptin, insulin and hypothalamic neuropeptide Y, J NEUROCHEM, 79(5), 2001, pp. 1004-1012
Authors:
Whitehouse, AS
Smith, HJ
Drake, JL
Tisdale, MJ
Citation: As. Whitehouse et al., Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid, CANCER RES, 61(9), 2001, pp. 3604-3609
Authors:
Islam-Ali, B
Khan, S
Price, SA
Tisdale, MJ
Citation: B. Islam-ali et al., Modulation of adipocyte G-protein expression in cancer cachexia by a lipid-mobilizing factor (LMF), BR J CANC, 85(5), 2001, pp. 758-763
Authors:
Lorite, MJ
Smith, HJ
Arnold, JA
Morris, A
Thompson, MG
Tisdale, MJ
Citation: Mj. Lorite et al., Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF), BR J CANC, 85(2), 2001, pp. 297-302
Citation: Je. Belizario et al., Cleavage of caspases-1, -3, -6, -8 and -9 substrates by proteases in skeletal muscles from mice undergoing cancer cachexia, BR J CANC, 84(8), 2001, pp. 1135-1140
Citation: Bs. Islam-ali et Mj. Tisdale, Effect of a tumour-produced lipid-mobilizing factor on protein synthesis and degradation, BR J CANC, 84(12), 2001, pp. 1648-1655
Citation: As. Whitehouse et Mj. Tisdale, Downregulation of ubiquitin-dependent proteolysis by eicosapentaenoic acidin acute starvation, BIOC BIOP R, 285(3), 2001, pp. 598-602
Citation: Sj. Wigmore et al., Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer, NUTR CANCER, 36(2), 2000, pp. 177-184
Citation: Hj. Hussey et Mj. Tisdale, Effect of the specific cyclooxygenase-2 inhibitor meloxicam on tumour growth and cachexia in a murine model, INT J CANC, 87(1), 2000, pp. 95-100
Authors:
Bing, C
Brown, M
King, P
Collins, P
Tisdale, MJ
Williams, G
Citation: C. Bing et al., Increased gene expression of brown fat uncoupling protein (UCP)1 and skeletal muscle UCP2 and UCP3 in MAC16-induced cancer cachexia, CANCER RES, 60(9), 2000, pp. 2405-2410
Citation: Sj. Wigmore et al., Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factor, BR J SURG, 87(1), 2000, pp. 53-58
Authors:
Hussey, HJ
Todorov, PT
Field, WN
Inagaki, N
Tanaka, Y
Ishitsuka, H
Tisdale, MJ
Citation: Hj. Hussey et al., Effect of a fluorinated pyrimidine on cachexia and tumour growth in murinecachexia models: relationship with a proteolysis inducing factor, BR J CANC, 83(1), 2000, pp. 56-62
Citation: Hj. Smith et al., Effect of a cancer cachectic factor on protein synthesis/degradation in murine C2C12 myoblasts: Modulation by eicosapentaenoic acid, CANCER RES, 59(21), 1999, pp. 5507-5513
Authors:
Barber, MD
Ross, JA
Voss, AC
Tisdale, MJ
Fearon, KCH
Citation: Md. Barber et al., The effect of an oral nutritional supplement enriched with fish oil on weight loss in patients with pancreatic cancer, BR J CANC, 81(1), 1999, pp. 80-86
Citation: Hj. Hussey et Mj. Tisdale, Effect of a cachectic factor on carbohydrate metabolism and attenuation byeicosapentaenoic acid, BR J CANC, 80(8), 1999, pp. 1231-1235
Citation: Pt. Todorov et al., Role of a proteolysis inducing factor (PIF) in cachexia induced by a humanmelanoma (G361), BR J CANC, 80(11), 1999, pp. 1734-1737